Lu AF35700Alternative Names: Lu AF356152 prodrug; Lu-AF35700
Latest Information Update: 12 Nov 2016
At a glance
- Originator Lundbeck A/S
- Class Neuropsychotherapeutics
- Mechanism of Action Dopamine D2 receptor modulators
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity Yes
Highest Development Phases
- Phase III Schizophrenia
- Phase I Schizoaffective disorder